HRT Financial’s IceCure Medical ICCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73K Buy
15,151
+13,564
+855% +$98K ﹤0.01% 3692
2026
Q1
$14K Buy
1,587
+1,075
+210% +$19.6K ﹤0.01% 3603
2025
Q4
$9K Sell
512
-1,045
-67% -$23.5K ﹤0.01% 3047
2025
Q3
$47K Buy
1,557
+996
+178% +$29.7K ﹤0.01% 2609
2025
Q2
$16K Buy
+561
New +$18K ﹤0.01% 2418
2024
Q4
Sell
-450
Closed -$8K 2777
2024
Q3
$8K Buy
+450
New +$9.13K ﹤0.01% 2238
2024
Q2
Sell
-624
Closed -$22K 2600
2024
Q1
$22K Sell
624
-627
-50% -$24.5K ﹤0.01% 2004
2023
Q4
$40K Buy
+1,251
New +$33.1K ﹤0.01% 1975

Other funds holding ICCM

HRT Financial's ICCM Position: Q2 2026 in Review

HRT Financial increased its IceCure Medical (ICCM) stake by 855% in Q2 2026, buying an estimated $98K and bringing the position to 15,151 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #3692.

HRT Financial first reported a position in ICCM in Q4 2023 and has held it in 8 quarters since. 11 funds tracked by Wall St. Rank hold ICCM as of Q2 2026.

  • HRT Financial held 15,151 shares of IceCure Medical worth $73K as of Q2 2026.
  • HRT Financial bought 13,564 IceCure Medical shares in Q2 2026, an estimated $98K.
  • IceCure Medical made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3692 holding.
  • HRT Financial first reported a position in IceCure Medical in Q4 2023 and has held it in 8 quarters since.
  • 11 funds tracked by Wall St. Rank held IceCure Medical as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.